Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
8.99
+0.01 (0.11%)
At close: Nov 14, 2025, 4:00 PM EST
9.00
+0.01 (0.11%)
After-hours: Nov 14, 2025, 7:20 PM EST
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $705.21 million as of November 14, 2025. Its market cap has decreased by -14.77% in one year.
Market Cap
705.21M
Enterprise Value
457.89M
1-Year Change
-14.77%
Ranking
Category
Stock Price
$8.99
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $705.21M, an increase of 50.84%. That is a compound annual growth rate of 5.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 705.21M | -24.33% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 245.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.81B |
| Johnson & Johnson | 467.89B |
| AbbVie | 405.60B |
| UnitedHealth Group | 307.99B |
| AstraZeneca | 275.02B |
| Novartis AG | 249.68B |
| Merck & Co. | 227.09B |
| Abbott Laboratories | 220.92B |